Amylyx Pharmaceuticals, Inc. (AMLX) Insider Ownership

Historic Insider Ownership Trends

Based on data from the past 90 days ending February 07, 2026, Amylyx Pharmaceuticals's three largest insider shareholders are TenPercentOwner Venture Investments Ltd Morningside (15.68Mn shares), Director Isaac Cheng (10.42Mn shares), TenPercentOwner Invest 1 B.V. Als (5.90Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Venture Investments Ltd Morningside 15,676,110 17 Aug, 2023
Isaac Cheng 10,422,228 10 Jan, 2022
Invest 1 B.V. Als 5,895,280 08 Jul, 2022
Joshua B Cohen Co Chief Executive Officer 3,363,965 04 Feb, 2026
Justin B. Klee Co Chief Executive Officer 3,363,898 04 Feb, 2026
Global Investors Lp Viking 1,850,940 09 Sep, 2022
George M Jr Milne 812,881 14 Jan, 2026
Margaret Olinger Chief Commercial Officer 276,108 29 Dec, 2023
Patrick D Yeramian Chief Medical Officer 205,605 11 Jan, 2024
James M Frates Chief Financial Officer 184,619 04 Feb, 2026
Camille L Bedrosian Chief Medical Officer 175,756 03 Dec, 2025
Gina Mazzariello Chief Legal Officer 144,693 04 Feb, 2026
Karen Firestone 63,100 23 Dec, 2025
Bernhardt G Zeiher 10,000 24 Mar, 2025
Daphne Quimi 5,000 16 May, 2024
Paul R. Fonteyne 3,947 10 Jan, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
02 Feb, 2026 James M Frates Common Stock D 3,557 $14.65 173,547 D S
02 Feb, 2026 Justin B. Klee Common Stock D 15,500 $14.68 3,363,898 D S
02 Feb, 2026 Joshua B Cohen Common Stock D 15,500 $14.68 3,363,965 D S
02 Feb, 2026 Gina Mazzariello Common Stock D 3,448 $14.65 144,693 D S
16 Jan, 2026 Justin B. Klee Common Stock D 1,995 $13.89 3,379,398 D S
16 Jan, 2026 Justin B. Klee Common Stock A 2,847 $7.57 3,381,393 D M
16 Jan, 2026 Joshua B Cohen Common Stock D 1,974 $13.83 3,379,465 D S
16 Jan, 2026 Joshua B Cohen Common Stock A 2,818 $7.57 3,381,439 D M
15 Jan, 2026 Justin B. Klee Common Stock A 197,153 $7.57 3,514,739 D M
15 Jan, 2026 Justin B. Klee Common Stock D 136,193 $13.58 3,378,546 D S
15 Jan, 2026 Joshua B Cohen Common Stock A 197,182 $7.57 3,514,814 D M
15 Jan, 2026 Joshua B Cohen Common Stock D 136,193 $13.59 3,378,621 D S
12 Jan, 2026 George M Jr Milne Common Stock D 17,780 $0.00 812,881 D G
06 Jan, 2026 James M Frates Common Stock D 3,326 $11.11 177,104 D S
06 Jan, 2026 Justin B. Klee Common Stock D 7,715 $11.09 3,317,586 D S
06 Jan, 2026 Joshua B Cohen Common Stock D 7,715 $11.09 3,317,632 D S
23 Dec, 2025 Karen Firestone Common Stock A 8,100 $12.45 63,100 D P
23 Dec, 2025 Karen Firestone - - 63,100 D
01 Dec, 2025 Camille L Bedrosian - - 175,756 D
01 Dec, 2025 Camille L Bedrosian Common Stock D 6,580 $14.35 175,756 D S